Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Mitsubishi Tanabe Pharma America Inc.
August 7, 2025
Mitsubishi Tanabe Pharma America Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of amyotrophic lateral sclerosis
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
